South Korea's 3D imaging market is projected to grow from $0.44 Bn in 2022 to $1.61 Bn by 2030, registering a CAGR of 17.5% during the forecast period of 2022-30. The market will be driven by the implementation of new 3D imaging technology, applications, and support from the government sector. The market is segmented by product, by application, end-user & by portability. Some of the major players include GE Healthcare, Siemens Healthineers & Samsung Medison.
Sweden's 3D imaging market is projected to grow from $xx Bn in 2022 to $0.11 Bn by 2030, registering a CAGR xx% during the forecast period of 2022-30. The market will be driven by the increased frequency of chronic illnesses, the growing need for customized care & The Swedish government's efforts in healthcare and medical research. The market is segmented by product, application, by end-user & by portability. Some of the major players include GE Healthcare, Siemens Healthineers, and Philips Healthcare
Turkey's 3D imaging market is projected to grow from $0.24 Bn in 2022 to $0.85 Bn by 2030, registering a CAGR of 17% during the forecast period of 2022-30. The market will be driven by rising chronic illnesses & growing need for modern medical technology for precise diagnosis and treatments. The market is segmented by product, application, by end-user & by portability. Some of the major players include GE Healthcare, Siemens Healthineers, and Philips Healthcare
Ukraine's 3D imaging market is projected to grow from $xx Bn in 2022 to $xx Bn by 2030, registering a CAGR xx% during the forecast period of 2022-30. The market will be driven by the rising frequency of chronic illnesses and the requirement for precise and thorough imaging for diagnosis. The market is segmented by product, application, end-user & by portability. Some of the major players include GE Healthcare, Siemens Healthineers, Philips Healthcare, and Canon Medical Systems.
Venezuela's 3D imaging market is projected to grow from $xx Bn in 2022 to $xx Bn by 2030, registering a CAGR xx% during the forecast period of 2022-30. The market will be driven by increasing demand for modern medical technologies & potential for telemedicine to expand access to 3D Imaging technologies. The market is segmented by product, application, by end-user & by portability. Some of the major players include GE Healthcare, Siemens Healthineers, and Philips Healthcare.
The UAE Diabetes Devices Market is expected to witness growth from $114 Mn in 2022 to $213 Mn in 2030 with a CAGR of 8.20% for the forecasted year 2022-2030. The high prevalence of diabetes, the quick uptake of novel products, increased R&D efforts, and the raising awareness of diabetes preventive care are some major market drivers for diabetes devices in the UAE. The market is segmented by type and by the end user. Some key players in this market include Mecomed, Pioneer Medical Supplies, Johnson & Johnson, Philipps Healthcare, Medtronic, DSM N.V., Roche and Dexcom.
The Belgium Diabetes Devices Market is expected to witness growth from $50 Mn in 2022 to $87 Mn in 2030 with a CAGR of 7.20% for the forecasted year 2022-2030. The demand for diabetes devices in Belgium is being driven by the rising knowledge of diabetes and its complications. This is due to the fact that people with diabetes are beginning to understand how crucial it is to successfully manage their condition and monitor their blood sugar levels. The market is segmented by type and by the end user. Some key players in this market include Coloplast Belgium, Avanos Medical Belgium BVBA, Johnson & Johnson, Philipps Healthcare, Medtronic, DSM N.V., Roche and Dexcom.
The UK ECG Equipment Market is expected to witness growth from $232 Mn in 2022 to $350 Mn in 2030 with a CAGR of 5.30% for the forecasted year 2022-2030. The main cause of mortality in the UK is cardiovascular disease, and as the population ages and people lead unhealthy lifestyles, the prevalence of these diseases is rising. As a consequence, there is an increasing need for ECG equipment that can be used to identify and track these conditions. The market is segmented by product type and by the end user. Some key players in this market include LivaNova, Win Health Medical, Johnson & Johnson, Philipps Healthcare, Medtronic, DSM N.V., Roche and Dexcom.
The UAE ECG Equipment Market is expected to witness growth from $45 Mn in 2022 to $84 Mn in 2030 with a CAGR of 8.30% for the forecasted year 2022-2030. One of the major reasons propelling the expansion of the ECG equipment market is the rising prevalence of cardiac diseases in the United Arab Emirates. The market is segmented by product type and by the end user. Some key players in this market include Winray, Mena Medical Supplies, Johnson & Johnson, Philipps Healthcare, Medtronic, DSM N.V., Roche and Dexcom.
The Thailand ECG Equipment Market is expected to witness growth from $11 Mn in 2022 to $19 Mn in 2030 with a CAGR of 7.64% for the forecasted year 2022-2030. In Thailand's healthcare system, telehealth and remote monitoring technologies are now being used more frequently as a result of the COVID-19 outbreak. The use of ECG equipment is expected to increase in the upcoming years as it is a crucial tool for the remote monitoring of patients with cardiac conditions. The market is segmented by product type and by the end user. Some key players in this market include Xovic, Meticuly, Infus Medical, Pacific Healthcare Thailand, Johnson & Johnson, Philipps Healthcare, Medtronic, GE Healthcare, and Nihon Kohden.
The Malaysia ECG Equipment Market is expected to grow from $14 Mn in 2022 to $26 Mn in 2030 with a CAGR of 7.50% for the forecasted year 2022-2030. In Malaysia, individuals are becoming increasingly aware of the value of preventative healthcare and are actively seeking out early detection and monitoring of health concerns. ECG equipment that may be utilised for screening and early diagnosis of heart-related disorders is in high demand due to this trend. The market is segmented by product type and by the end user. Some key players in this market include Nipro Malaysia, Getz Healthcare, Johnson & Johnson, Philipps Healthcare, Medtronic, GE Healthcare, and Nihon Kohden.
The Japan ECG Equipment Market is expected to witness growth from $554 Mn in 2022 to $1010 Mn in 2030 with a CAGR of 7.80% for the forecasted year 2022-2030. There are a lot of elderly individuals in Japan who are at an increased risk of cardiovascular disease due to the country's rapidly ageing population. Japan now has a greater need for ECG equipment as a result of this demographic tendency. The market is segmented by product type and by the end user. Some key players in this market include Nihon Kohden, Fukuda Denshi, Roland dg, Johnson & Johnson, Philipps Healthcare, Medtronic and Dexcom.
The Indonesia ECG Equipment Market is expected to witness growth from $53 Mn in 2022 to $94 Mn in 2030 with a CAGR of 7.30% for the forecasted year 2022-2030. Indonesia is seeing an increase in the number of cardiac illnesses, which is driving up demand for ECG equipment for monitoring and diagnostics. The market is segmented by product type and by the end user. Some key players in this market include Graha Ismaya, PT Urogen Advanced Solutions, PT Transmedic, Johnson & Johnson, Philipps Healthcare, Medtronic, GE Healthcare, and Nihon Kohden.
The India ECG Equipment Market is expected to witness growth from $162 Mn in 2022 to $355 Mn in 2030 with a CAGR of 10.30% for the forecasted year 2022-2030. India has a high rate of heart attacks and arrhythmias, which is increasing the demand for ECG devices. The market is segmented by product type and by the end user. Some key players in this market include BPL Medical Technologies, Schiller India, Johnson & Johnson, Philipps Healthcare, Medtronic, Biolight and Dexcom.
The German ECG Equipment Market is expected to witness growth from $326 Mn in 2022 to $500 Mn in 2030 with a CAGR of 5.50% for the forecasted year 2022-2030. The ageing populace in Germany is increasing the demand for medical services, including ECG equipment. There is a growing need for ECG devices for diagnosis and monitoring as the population ages and the prevalence of heart disease and other cardiovascular conditions rises. The market is segmented by product type and by the end user. Some key players in this market include Rein Medical GmbH, KLS Martin, Johnson & Johnson, Philipps Healthcare, Medtronic, DSM N.V., Roche and Dexcom.
The France ECG Equipment Market is expected to witness growth from $245 Mn in 2022 to $399 Mn in 2030 with a CAGR of 6.30% for the forecasted year 2022-2030. France has a developed healthcare system with many hospitals and other healthcare services. With the construction of new hospitals and healthcare facilities, this infrastructure is growing, which presents possibilities for manufacturers of ECG equipment to provide equipment to these facilities. The market is segmented by product type and by the end user. Some key players in this market include 3dceram, Anatomic Modeling, Johnson & Johnson, Philipps Healthcare, Medtronic, DSM N.V., Roche and Dexcom.
The China ECG Equipment Market is expected to witness growth from $716 Mn in 2022 to $1406 Mn in 2030 with a CAGR of 8.80% for the forecasted year 2022-2030. In China, heart illness is one of the main causes of death and is becoming more common. Due to this, the need for ECG equipment to diagnose and track heart disease is on the rise. The market is segmented by product type and by the end user. Some key players in this market include Mindray, Edan Instruments, Johnson & Johnson, Philipps Healthcare, Medtronic, Biolight and Dexcom.
The Australia ECG Equipment Market is expected to witness growth from $107 Mn in 2022 to $210 Mn in 2030 with a CAGR of 8.80% for the forecasted year 2022-2030. The Australian government has recently increased healthcare spending, which is likely to fuel market expansion for ECG equipment. The market is segmented by product type and by the end user. Some key players in this market include Tomlin Medical, Anatomics, Johnson & Johnson, Philipps Healthcare, Medtronic, Biolight and Dexcom.
Australia women’s health market is projected to grow from $479 Mn in 2022 to $781 Mn by 2030, registering a CAGR of 6.30% during the forecast period of 2022-30. The Australian government has implemented a number of policies and programs aimed at promoting women's health, such as providing funding for cancer screenings and research on women's health issues through the Medicare Benefits Schedule (MBS). Companies such as Pfizer, AstraZeneca, and GlaxoSmithKline are major players in the Australia women's health market, producing drugs and supplements for conditions such as osteoporosis and menopause.
The France-connected healthcare market is projected to grow from $1.83 Bn in 2022 to $12.67 Bn by 2030, registering a CAGR of 27.4% during the forecast period of 2022 - 2030. The main factors driving the growth would be government support, health tech startups and the rising geriatric population. The market is segmented by type, function and by application. Some of the major players include Sanofi, Withings, Voluntis, Evolucare, Apple, Microsoft, Siemens Healthineers and Medtronic.
The China-connected healthcare market is projected to grow from $5.34 Bn in 2022 to $43.25 Bn by 2030, registering a CAGR of 29.9% during the forecast period of 2022 - 2030. The main factors driving the growth would be a large and ageing population, government support, technological advancements and a rising middle class. The market is segmented by type, function and by application. Some of the major players include Tencent Health, JD Health International, WeDoctor, iCarbonX, Roche, GE Healthcare and Medtronic.
By 2030, it is anticipated that the France Oncology Therapeutics Market will reach a value of $8.8 Bn from $4.9 Bn in 2022, growing at a CAGR of 7.4% during 2022-2030. The Oncology Therapeutics Market in France is dominated by a few domestic pharmaceutical companies such as Bristol Myers Squibb, Boehringer Ingelheim, and CureVac. The Oncology Therapeutics Market in France is segmented into different types of cancer and different therapy type. The major risk factors associated with cancer are diet, alcohol, tobacco, air pollution, and physical inactivity. The demand for France Oncology Therapeutics is increasing on account of the rise in initiatives taken by the Government of the country.
By 2030, it is anticipated that the China Oncology Therapeutics Market will reach a value of $31.1 Bn from $14.6 Bn in 2022, growing at a CAGR of 9.9% during 2022-2030. The Oncology Therapeutics Market in China is dominated by a few domestic pharmaceutical companies such as Bristol Myers Squibb, Boehringer Ingelheim, and CureVac. The Oncology Therapeutics Market in China is segmented into different types of cancer and different therapy type. The major risk factors associated with cancer are diet, alcohol, tobacco, air pollution, and physical inactivity. The demand for China Oncology Therapeutics is increasing on account of the rise in initiatives taken by the Government of the country.
India's dental care market was valued at $653 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 9.40% from 2022 to 2030 and will reach $1339 Mn in 2030. One of the main reasons propelling the growth of this market is the rising knowledge and awareness among individuals regarding dental aids and various treatments that aim to improve personal health and hygiene. Some key players in this market are Clove Dental, 3M, Dentsply Sirona, GE Healthcare, and Philips Healthcare.
The Romania Artificial Intelligence (AI) In Healthcare Market is projected to grow from $20.01 Mn in 2022 to $401.27 Mn by 2030, registering a CAGR of 45.47% during the forecast period of 2022 - 2030. The market will be driven by the increasing investment in AI infrastructure and expertise development to utilize AI Solutions. The market is segmented by healthcare components & by healthcare applications. Some of the major players include IBM Watson Health, Google Health & Synaptic.